IBT6A NEW

$ 42.00 /100mg

Min. Order
Purity99.88%
Cas No1022150-12-4
Supply Ability10g
Update time2024-11-19

TargetMol Chemicals Inc.

3YR

United States

Since2011-01-07

Address36 Washington Street, Wellesley Hills

show less show more

Chemical Properties

Product Name	IBT6A
CAS No	1022150-12-4
EC-No
Min. Order
Purity	99.88%
Supply Ability	10g
Release date	2024/11/19

Product Introduction

Bioactivity

Name	IBT6A
Description	IBT6A, an impurity of Ibrutinib, is a Btk inhibitor (IC50: 0.5 nM) that can be utilized in the synthesis of IBT6A Ibrutinib dimer and IBT6A adduct.
Storage	keep away from direct sunlight,keep away from moisture,store at low temperature \| Powder: -20°C for 3 years \| In solvent: -80°C for 1 year \| Shipping with blue ice.
Solubility Information	DMSO : 25 mg/mL (64.69 mM)
Keywords	Bruton tyrosine kinase \| Btk \| IBT6A \| inhibit \| IBT-6A \| Inhibitor
Inhibitors Related	evobrutinib \| (±)-Zanubrutinib \| CP-547632 \| BMS-986142 \| Edralbrutinib \| Sunvozertinib \| Ibrutinib \| Orelabrutinib \| Atuzabrutinib \| CGI-1746
Related Compound Libraries	Bioactive Compound Library \| Tyrosine Kinase Inhibitor Library \| Kinase Inhibitor Library \| Angiogenesis related Compound Library \| Inhibitor Library \| NO PAINS Compound Library \| Bioactive Compounds Library Max \| Covalent Inhibitor Library

show less show more

Company Profile Introduction

Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers. TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.